A familial modeling framework for advancing precision medicine for children with neuropsychiatric disorders
Developmental Medicine & Child Neurology · 2025
DOI: 10.1111/dmcn.16278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, 2025. Verfasst von Jennifer L Bruno und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interdisciplinary Brain Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Precision Medicine, Noonan Syndrome. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Child Health and Human Development, Neurofibromatosis Therapeutic Acceleration Program, NIA NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To provide individualized estimates of expected child neuropsychiatric and neuroanatomical outcomes by using parent cognitive and behavioral traits in a predictive framework.
Method
Predictive modeling was applied to 52 families of children with Noonan syndrome, a neurogenetic syndrome affecting the Ras/mitogen‐activated protein kinase (MAPK) pathway.
Results
Parent cognition (specifically visuospatial and motor abilities), depression, anxiety, and attention‐deficit/hyperactivity disorder symptoms were significantly associated with child outcomes in these domains. Parent cognition was also significantly associated with child neuroanatomical variability. The middle temporal cortex was weighted strongly in the model predicting child neuroanatomy and not identified in previous work, but was correlated with parent cognition, suggesting a larger familial effect in this region.
Interpretation
Using parent traits provides a more individualized estimate of expected child cognitive, behavioral, and neuroanatomical outcomes. Understanding how parent traits influence neuroanatomical outcomes helps to further a mechanistic understanding of the impact of Ras/MAPK on neurodevelopmental outcomes. Further refinement of predictive modeling to estimate individualized child outcomes will advance a precision medicine approach to treating Noonan syndrome, other neurogenetic syndromes, and neuropsychiatric disorders more broadly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Interdisciplinary Brain Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
ORCID-Profile: Jennifer L Bruno, S M Hadi Hosseini, Tamar Green
Förderung
- National Institute of Child Health and Human Development
- Neurofibromatosis Therapeutic Acceleration Program
- NIA NIH HHS
- NICHD NIH HHS
- Stephen Bechtel Endowed Faculty Scholar in Pediatric Translational Medicine
- Stanford Maternal & Child Health Research Institute
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute on Aging
Zitieren
APA
Bruno, J. L., Merrin, J. J., Hosseini, S. M. H., & Green, T. (2025). A familial modeling framework for advancing precision medicine for children with neuropsychiatric disorders. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.16278
Vancouver
Bruno JL, Merrin JJ, Hosseini SMH, Green T. A familial modeling framework for advancing precision medicine for children with neuropsychiatric disorders. Developmental Medicine & Child Neurology. 2025. doi:10.1111/dmcn.16278
BibTeX
@article{Bruno2025,
author = {Bruno, Jennifer L and Merrin, Jacob Joseph and Hosseini, S M Hadi and Green, Tamar},
title = {A familial modeling framework for advancing precision medicine for children with neuropsychiatric disorders},
journal = {Developmental Medicine & Child Neurology},
year = {2025},
doi = {10.1111/dmcn.16278}
}
EUVIMED